Pharmaceuticals, Life Science
Balancing the needs of QA/QC and speed to market can be an intricate process and requires a diverse range of products to ensure success and regulatory compliance. From discovery to research on new drug candidates to method development and ensuring ultra-pure water, Shimadzu can accelerate your process with a full lineup of analytical instruments.
Backed by the most advanced software available, you'll have complete confidence as you seek to unravel the mysteries of science.
Learn more about the Pharmaceutical Development Process
In the rapidly changing Biotech environment, innovative technologies are needed to keep pace with this ever-expanding world of discovery. Shimadzu understands your challenge and the desire that leads to vital advancements in the knowledge of biotechnology.
Applying a wealth of R&D expertise, Shimadzu offers strong solutions-based instrumentation covering technologies from DNA sequencing to high-performance mass spectrometry to accelerate the progress of your biotechnology research and development.
Shimadzu understands that the development of new pharmaceuticals generally entails two major activities: Drug Discovery and Drug Development. In a Drug Discovery program, the goal is to qualitatively investigate a large number of compounds, narrow the selection through more targeted synthesis and screening (lead optimization), and finally to select potentially viable therapeutic candidates. It is then the responsibility of Drug Development to completely characterize candidate compounds by performing drug metabolism, pre-clinical and clinical screening, clinical trials, QA/QC, and eventually develop a means of manufacturing the final product.
Shimadzu recognizes your needs, and provides analytical tools with a great deal of flexibility in both hardware and software to ensure successful implementation.
The intense pace of progress in research advances in the area of proteomics has been astounding. Various strategies have been implemented in the continuing quest to unveil the characteristics of protein structure, function, mechanisms of protein-protein interaction, biomarkers, and more. This unprecedented progress demands concurrent progress for better tools and technology.
Shimadzu has always had its finger on the pulse of cutting-edge research, and continues to develop instruments and collaborations with strategic alliances to provide you with the necessary solutions for discovery.
Learn more about proteomics in the Life Science section of our web site.
In the broadest sense, the term "Biologics" refers to any component or process of a living organism. However, a more narrow interpretation of the term has come into widespread use to include a wide range of medicinal products such as vaccines, blood and blood components, allergenics, somatic cells, gene therapy, tissues, and recombinant therapeutic proteins.
Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. They can be isolated from a variety of natural sources - human, animal, or microorganism - and may be produced by biotechnology methods and other technologies. Gene-based and cellular biologics may be used to treat a variety of medical conditions.
Biologics as a class of medications in this narrower sense have had a profound impact on many medical fields, primarily rheumatology and oncology, but also cardiology, dermatology, gastroenterology, and neurology. The challenge faced by providers of analytical instruments is to develop new technologies and adapt existing instruments and accessories to meet the demands of this emerging class of analytes.